News Archive of Biotech News - Business Wire

ArticleAdded
TheraVida Announces Publication of Phase 2 Results for THVD-102 in Hyperhidrosis02-27-17
Arrakis Therapeutics Announces $38 Million Series A Financing to Target RNA with Small-Molecule Medicines and Names Michael Gilman Chairman and CEO02-27-17
Glaukos Announces Participation in 29th Annual ROTH Conference02-27-17
Exelixis Announces Clinical Trial Collaboration with Roche to Evaluate Cabozantinib and Atezolizumab in Locally Advanced or Metastatic Solid Tumors02-27-17
Inotek Pharmaceuticals Announces Participation at Upcoming Investor Conferences02-27-17
Global Bacterial Partnering Deals and Agreements Between the World's Leading Pharmaceutical and Biotechnology Companies 2010-2017 - Research and Markets02-27-17
Arsanis and Adimab Enter Into License Agreement to Target Respiratory Syncytial Virus (RSV) With Monoclonal Antibodies02-27-17
Sunovion Announces Positive Topline Results from Study Evaluating Latuda® (lurasidone HCl) in Children and Adolescents with Bipolar Depression02-27-17
Mersana Therapeutics to Present at the Cowen and Company 37th Annual Health Care Conference02-27-17
InVivo Therapeutics to Present at Cowen and Company 37th Annual Health Care Conference02-27-17
Ignyta Announces Multiple Presentations at the 2015 AACR Annual Meeting04-18-15
Meeting the Needs of Ophthalmologists: ZEISS Showcases Integrated Solutions that Deliver Faster Practice and Surgical Workflow and Address Critical Diagnostic Challenges04-18-15
SanBio Presents at Annual European Stroke Organisation Conference04-18-15
La bioéconomie du Canada, en pleine croissance, sera la vedette du Congrès mondial BIO 2015 sur la biotechnologie industrielle, organisé à Montréal04-18-15
A Cure for Global Warming plus Drought Relief04-17-15
Full Data on Baxter's Investigational Recombinant Treatment BAX 111 Supports Potential Role to Treat von Willebrand Disease04-17-15
Epizyme Announces Closing of Common Stock Offering04-17-15
Pernix Therapeutics Inc. to Report First Quarter 2015 Financial Results04-17-15
Exactech Announces First Quarter 2015 Earnings Release Date and Updates First Quarter Estimates04-17-15
THERAVECTYS SECURISE AUPRES DE L?INSTITUT CURIE UN ACCES EXCLUSIF A UNE BANQUE DE NANOBODIES HUMAINS SYNTHETIQUES ET RENFORCE SA PLATEFORME IMMUNOTHERAPEUTIQUE04-17-15
FDA Approves Only ICD with Ultra-High Energy on the First Shock04-17-15
BioNJ & NJDLWD Present New Jersey Life Sciences Week, April 20-2404-17-15
Canada's Growing Biobased Economy To Be Showcased at the 2015 BIO World Congress on Industrial Biotechnology in Montreal04-17-15
New international survey of lung cancer oncologists highlights underutilization of personalized treatments04-17-15
Anika Therapeutics Reports on Cingal® 13-01 Study Clinical Trial Top Line Data and Announces the Completion of Cingal 13-02 Study's Patient Enrollment04-17-15
Samenvatting: MedDay: onderzoek naar behandeling MS met MD1003 behaalt primair eindpunt04-17-15
Avipep's Clinical Study of AVP-04 in Ovarian and Prostate Cancer Selected for Oral Presentation at AACR04-17-15
Research and Markets: Funding Patterns in the Global Pharma and Biotech Industry04-17-15
Results of Phase III Study of Brexpiprazole in Adult Patients with Schizophrenia Published in American Journal of Psychiatry04-17-15
Sartorius Stedim Biotech erwirbt britisches Unternehmen BioOutsource04-17-15
Sartorius Stedim Biotech acquires UK-based CRO, BioOutsource04-17-15
Ferring anuncia la aprobación en Europa de la nueva formulación estable a temperatura ambiente de DURATOBAL® (carbetocina)04-17-15
Resumen: MedDay ha anunciado que su estudio fundamental de fase III de MD1003 en pacientes con esclerosis múltiple progresiva satisface el criterio principal de evaluación04-17-15
?????????????????????????????04-17-15
Cavion Collaborators Present Data at AACR04-17-15
?????????????????????????????04-17-15
Samenvatting: Quintiles en Hospital Italiano van Buenos Aires kondigen overeenkomst aan04-17-15
Osiris Therapeutics Announces First Quarter 2015 Financial Results Conference Call04-17-15
ConforMIS Announces Settlement of Patent Infringement Lawsuits04-17-15
Medican Enterprises Extends Closing on Two Phoenix Area Properties04-17-15
Teva to Report First Quarter 2015 Financial Results on April 30, 201504-17-15
ConforMIS gibt Einigung bei Patentverletzungsklagen bekannt04-17-15
Ferring meldet europäische Zulassung der neuen raumtemperaturstabilen Formulierung von PABAL® (Carbetocin)04-17-15
Midatech Pharma PLC: Preliminary results for the year ending 31 December 201404-17-15
ARIAD Presents Updated Clinical Data on Brigatinib in Patients with ALK+ Non-Small Cell Lung Cancer04-17-15
Incyte's Emerging Development Pipeline Described in Eleven Abstracts at 2015 AACR Annual Meeting04-17-15
Fluxion Biosciences Introduces the IsoFlux? EMT Enrichment Kit for More Comprehensive Circulating Tumor Cell Analysis04-17-15
Research and Markets: ADME-Toxicology Testing (In-Vivo, & In-Vitro) Market - Global Strategic Business Report 201504-17-15
Sarah Cannon Research Institute to Present 19 Abstracts at the American Association for Cancer Research Annual Meeting04-17-15
MedDay announces its pivotal Phase III study of MD1003 in patients with Progressive Multiple Sclerosis meets primary endpoint04-17-15
Riassunto: MedDay annuncia che il suo studio pivotale di fase 3 di MD1003 in pazienti affetti da sclerosi multipla progressiva ha raggiunto l'endpoint primario04-17-15
MedDay annonce l?atteinte du critère principal de son étude pivot de phase III sur le MD1003 chez des patients atteints de sclérose en plaques progressive04-17-15
MedDay gibt bekannt, dass die zulassungsrelevante Phase-III-Studie zu MD1003 bei Patienten mit progredienter multipler Sklerose den primären Endpunkt erreicht hat04-17-15
NeuroVive Pharmaceutical: Development of NVP014 for the Treatment of Stroke Enters New Phase in Collaboration with Isomerase Therapeutics04-17-15
Quintiles und das Hospital Italiano de Buenos Aires geben Vereinbarung zur Beschleunigung klinischer Entwicklung bekannt04-17-15
Quintiles y el Hospital Italiano de Buenos Aires Anuncian su Acuerdo para Acelerar el Desarrollo Clínico04-17-15
Quintiles et l?hôpital italien de Buenos Aires annoncent un accord pour accélérer le développement clinique04-17-15
Akebia Therapeutics Prices Public Offering of Common Stock04-17-15
Quintiles e Hospital Italiano de Buenos Aires anunciam acordo para acelerar o desenvolvimento clínico04-16-15
Introducing the Westchester County Association's ?Face Time for Entrepreneurs? ? a Once-in-a-Lifetime Opportunity for Startups to Pitch Their Products Directly to Senior Hospital Decision Makers ? and Maybe Make a Sale!04-16-15
MTTI and National Health Research Institutes present a Novel Cancer Therapeutic at 2015 AACR04-16-15
BIO Supports Trade Promotion Authority04-16-15
TransEnterix Announces Completion of GLP Studies04-16-15
Research and Markets: Top 50 Big Biotech Partnering and M&A Deal Trends Report 201504-16-15
Harvard Apparatus Regenerative Technology Reports CEO Transition04-16-15
PharMerica Corporation Announces First Quarter 2015 Earnings Call and Webcast04-16-15
Netsmart OrderConnect? e-Prescribing Solution Attains Certification for Controlled Substances04-16-15
Clarity Medical's RetCam Will Be Used in a Worldwide Clinical Study for the Treatment of Premature Infant Ocular Disease04-16-15
Research and Markets: Global Co-development Deals in Pharma, Biotech & Diagnostics 2010-201504-16-15
Pfizer Invites Public to Listen to Webcast of April 23 Annual Meeting of Shareholders04-16-15
Research and Markets: Finding Biopharma Licensing and Collaboration Partners: 2015 Guide04-16-15
Riassunto: Quintiles e Hospital Italiano di Buenos Aires annunciano la stipula di un accordo per l?accelerazione dello sviluppo clinico04-16-15
Lilly, Bristol-Myers Squibb Restructure Erbitux® (cetuximab) Collaboration in North America04-16-15
Eleven Biotherapeutics Presents Phase 2 Clinical Data on EBI-005 for the Treatment of Allergic Conjunctivitis at ASCRS 2015 Annual Meeting04-16-15
STENTYS Reports First Quarter 2015 Revenues Rose 28%04-16-15
Transgene SA: Agreement with FDA Announced for Special Protocol Assessment for Upcoming Phase 3 Pexa-Vec Trial in Advanced Liver Cancer04-16-15
Transgene SA : La future phase 3 de Pexa-Vec dans le cancer avancé du foie vient de recevoir l?accord de la Food and Drug Administration américaine pour une procédure spéciale de revue du protocole04-16-15
St. Cloud Surgical Center Announces First Ambulatory Surgical Center in Minnesota to Implement CT-Free Robotics-Assisted Orthopedic Surgery04-16-15
Blue Belt Technologies Announces First Ambulatory Surgery Center in Minnesota to Perform a CT-Free Robotics-Assisted Partial Knee Replacement04-16-15
Samenvatting: Sequana Medical sluit marketing- en distributieovereenkomst met Fresenius over alfapump-systeem04-16-15
Cystic Fibrosis Foundation Therapeutics Announces $14 Million Research Expansion with Genzyme04-16-15
Atox Bio Announces Oral Presentation at the 35th Annual Meeting of the Surgical Infection Society04-16-15
PsiOxus Therapeutics to Present Promising New Data on Novel Oncolytic Immunoncology Platform at AACR 201504-16-15
PsiOxus Therapeutics Expands Clinical Studies for Immuno-Oncolytic Treatment Following Positive Response to Intravenous Delivery04-16-15
22nd Century Group Announces Launch of ?0.0 mg Nicotine? MAGIC Cigarettes in Spain04-16-15
Caribou Biosciences Co-Founder Dr. Jennifer Doudna Named to TIME Magazine's TIME 100 - TIME's Annual List of the 100 Most Influential People in the World04-16-15
Rosetta Genomics Receives Key U.S. Patent Allowance for its Cancer of Origin Diagnostic Assay04-16-15
Asklepios Executes License with Benitec04-16-15
Seattle Genetics Highlights Broad Presence at the American Association for Cancer Research (AACR) Annual Meeting04-16-15
Baxter Submits Application to Japan's MHLW for Approval of BAX 855, Extended Half-Life Recombinant FVIII Based on ADVATE for Hemophilia A04-16-15
Targacept Announces Negative Top-Line Results from Exploratory Study of TC-6499 in Diabetic Gastroparesis04-16-15
Pfizer Launches 2014 Integrated Annual Review04-16-15
Protalex Announces Findings from Final Cohort of U.S. Phase 1b Trial of PRTX-100 in Active Rheumatoid Arthritis Patients04-16-15
Allena Pharmaceuticals Appoints Louis Brenner, M.D. as Chief Operating Officer04-16-15
Isarna Initiates First-in-Human Phase I Trial for ISTH0036 to Treat Advanced Glaucoma04-16-15
RainDance Technologies Extends Global Commercial Reach with Distributor Appointments in Europe and Middle East04-16-15
InVivo Therapeutics Announces Uplisting to Nasdaq04-16-15
Quintiles and Hospital Italiano of Buenos Aires Announce Agreement to Accelerate Clinical Development04-16-15
Ironwood Pharmaceuticals Appoints Lawrence Olanoff, M.D., Ph.D., to Board of Directors04-16-15
Molecular Templates Presents Preclinical Data on De-Immunized Engineered Toxin Bodies (ETB) with Novel Immuno-Oncology Capabilities at the 2015 AACR Annual Meeting04-16-15
Alise Reicin Joins Merck Serono as Head of Global Clinical Development04-16-15
Dyax Corp. to Host First Quarter 2015 Earnings Call and Webcast04-16-15
BioCision and Brooks Joint Development Partnership to Unveil New Cryogenic Sample Handling and Transport Product04-16-15
Synta Announces Presentations at the 2015 Annual Meeting of the American Association of Cancer Research04-16-15
ASEA Makes Its Debut as One of Direct Selling News? Top Direct Selling Companies in the World04-16-15
Intensity Therapeutics, Inc.'s Research Selected for Presentation at the 2015 American Association for Cancer Research Annual Meeting04-16-15
Cerulean Announces Three Posters to be Presented with Preclinical CRLX101 Data at the American Association for Cancer Research Annual Meeting04-16-15
Teleflex Announces First Quarter 2015 Earnings Conference Call Information04-16-15
NovaBay Signs Distribution Agreement with AmerisourceBergen Corporation for Avenova04-16-15
?????????????????????04-16-15
Pacira Receives Subpoena from the U.S. Department of Justice04-16-15
Resumen: Sequana Medical suscribe acuerdo de colaboración con Fresenius Medical Care para el marketing y distribución del sistema alfapump®.04-16-15
Medicinal Genomics Corporation Launches PathogINDICAtor?, A Novel and Automated Microbial Screening Kit for Cannabis04-16-15
Ovid Therapeutics Appoints Dr. Jeremy Levin as Chief Executive Officer04-16-15
Dolphin and Whale Researchers Will Use ndd Medical's PFT Technology to Understand Lung Function04-16-15
Lundbeck and Ovid Therapeutics Announce Exclusive Worldwide Licensing Agreement for Gaboxadol04-16-15
Sequana Medical signs collaboration agreement with Fresenius Medical Care for the marketing and distribution of the alfapump® system.04-16-15
Sequana Medical unterzeichnet Kooperationsvereinbarung mit Fresenius Medical Care für Vertrieb seines alfapump® Systems04-16-15
Sequana Medical signe un accord de collaboration avec Fresenius Medical Care pour le marketing et la distribution du système alfapump®.04-16-15
Riassunto: Sequana Medical sigla un accordo di collaborazione con Fresenius Medical Care per il marketing e la distribuzione del sistema alfapump®.04-16-15
Applied Spectral Imaging Received South Korean Ministry of Food and Drug Safety (MFDS) Clearance for GenASIs? HiPath IHC Family for HER2, ER, PR and Ki6704-16-15
Active Biotech and Ipsen Announce Their Decision to Discontinue the Development of tasquinimod in Prostate Cancer04-16-15
Active Biotech et Ipsen annoncent leur décision d?arrêter le développement du tasquinimod dans le cancer de la prostate04-16-15
Enanta Pharmaceuticals Announces AbbVie's Investigational Treatment Regimen for Genotype 1 Chronic Hepatitis C Granted Priority Review in Japan04-15-15
Representative Lance Honored as BIO Legislator of the Year04-15-15
Cellectis Plant Sciences, Inc. Locks Early CRISPR Intellectual Property Uses in Plants04-15-15
Cellectis Plant Sciences acquiert des droits de propriété intellectuelle sur la technologie CRISPR appliquée aux plantes04-15-15
FDA Advisory Committee Recommends Approval of The Medicines Company's Antiplatelet Therapy Cangrelor04-15-15
Senator Coons Honored as BIO Legislator of the Year04-15-15
Representative Conyers Honored as BIO Legislator of the Year04-15-15
Provectus Biopharmaceuticals Opens Patient Enrollment; Begins Phase 3 International FDA Comparative Clinical Trial of PV-10 for Melanoma04-15-15
Senator Toomey Honored as BIO Legislator of the Year04-15-15
Research and Markets: United States Off-Label Drugs Market & Forecasts 201504-15-15
Anika Therapeutics Announces Date of First-Quarter 2015 Financial Results Conference Call04-15-15
Bard Declares Quarterly Dividend04-15-15
Transgenomic Provides Financial and Business Update04-15-15
Xenex Germ-Zapping Robots Arrive in Spain; Clece Chooses Xenex for Hospital Disinfection04-15-15
Ironwood Pharmaceuticals to Host First Quarter 2015 Investor Update Call04-15-15
Expert Presents Significant Body of Data from Randomized Controlled Trials of EndoGastric Solutions®? Transoral Incisionless Fundoplication (TIF®) Procedure for GERD at SAGES 201504-15-15
CIO Review Names Paragon Solutions for 20 Most Promising Pharma and Life Sciences Consulting Providers04-15-15
BayBio Institute Names Amgen Bay Area Winners04-15-15
AIT Bioscience Names Terri Pascarelli as New CEO04-15-15
SpineGuard Announces Adoption of Its DSG® Technology by the 15th French-Based Spine-Teaching Institution04-15-15
Recurso de suporte à decisão clínica UpToDate da Wolters Kluwer integra-se à solução de prontuário eletrônico da MV04-15-15
Wolters Kluwer Anuncia la Integración del Sistema de Apoyo para Toma de Decisiones Médicas de UpToDate con el Expediente Clínico Electrónico de MV04-15-15
Wolters Kluwer Announces UpToDate Clinical Decision Support Integration with MV Electronic Health Record04-15-15
MEDIAN Technologies: Publication of the Annual Report for Financial Year 201404-15-15
MEDIAN Technologies: 2014 Results04-15-15
MEDIAN Technologies : Mise à disposition du rapport financier annuel04-15-15
MEDIAN Technologies : Résultats 201404-15-15
Estudo mostra que traço de eficiência do uso de nitrogênio aumenta a biomassa da cana-de-açúcar04-15-15
Hospital Corporation of America Signs Research Agreement with Harvard Pilgrim Health Care Institute04-15-15
Biologics, Inc. Secures Over $29 Million in Copay Assistance for Cancer Patients in 201404-15-15
ReSound® Develops First Hearing Aid App for Apple Watch04-15-15
Ophthalmology-focused CROs, Iris Pharma and Oculos Clinical Research Announce Strategic Alliance to Offer International Specialized Services to the Ophthalmic Market04-15-15
PerkinElmer??????????????????04-15-15
Full-Service CRO CTI Broadens Use of Medidata Technology Platform for More Efficient, Higher Quality Clinical Trials04-15-15
XenoPort to Present New Data Analyses for HORIZANT (gabapentin enacarbil) at the 67th Annual Meeting of the American Academy of Neurology04-15-15
Guided Therapeutics Completes Interim Financing; Initiating Distribution of LuViva® Advanced Cervical Scan in China04-15-15
Syros Pharmaceuticals to Present New Data from its Gene Control Platform in AML and Breast Cancer at AACR Annual Meeting 201504-15-15
Avant Diagnostics, Inc. Begins OvaDx FDA Trials and Engages Clinical Research Organization04-15-15
Asana BioSciences to Present Preclinical Data for a Novel Dual Inhibitor of SYK and JAK Family Kinases and a 5T4-Targeted Antibody Drug Conjugate at the AACR Annual Meeting in Philadelphia, April 18-22, 201504-15-15
PatientsLikeMe Study Monitors Walking Activity in People with MS04-15-15
Biothera Immunotherapy Combination Results in Tumor Reduction During Maintenance Phase of Non-Small Cell Lung Cancer Study04-15-15
Tenax Therapeutics Provides Clinical and Corporate Update04-15-15
Benchling Launches Cloud Platform to Accelerate Life Science R&D04-15-15
Macrophage Therapeutics Announces Manocept? Results in Kaposi's Sarcoma Studies to Be Presented at the American Association of Cancer Research (AACR)04-15-15
Navidea Announces Lymphoseek® Presentations at Upcoming Medical Conferences04-15-15
Veeva Systems Introduces Global Key Opinion Leader (KOL) Data and Services Solution04-15-15
The Medicines Company Stock Trading Halted Today04-15-15
Jounce Therapeutics to Present at the Jefferies 2015 Immuno-Oncology Summit04-15-15
Envisia Therapeutics to Present at the Ophthalmology Innovation Summit04-15-15
Study Shows Nitrogen Use Efficiency Trait Increases Biomass of Sugarcane04-15-15
Cerulean to Present at 14th Annual Needham Healthcare Conference04-15-15
BioDirection, Inc. Selected to Present at Cavendish Global Health Impact Forum04-15-15
BIO Commends House Judiciary Committee's Review of The Innovation Act04-15-15
?????????????????????????????????????????????????????????????????04-15-15
Resumen: THERAVECTYS se asegura el acceso exclusivo a una biblioteca de nanocuerpos humanizados sintéticos del Institut Curie y consolida su propia plataforma de terapias inmunológicas04-15-15
Samenvatting: THERAVECTYS krijgt exclusieve toegang tot synthetische vermenselijkte nanolichamen van kameelachtigen van het Institut Curie04-15-15
Research and Markets: Global Life Science and Chemical Instrumentation Market Report 2015-201904-15-15
PerkinElmer Launches First Fully Automated Genetic Disorder Screening System in China04-15-15
Samenvatting: Sartorius: aanvullende informatie over boekjaar 201404-15-15
OMEICOS Therapeutics Raises EUR 6.2 Million in Series A to Advance Lead Candidate in Atrial Fibrillation04-15-15
IncellDx, Inc.?Claremont BioSolutions??????????????????04-15-15
IncellDx, Inc.?Claremont BioSolutions??????????????????04-15-15
IOmet Pharma Announces the Appointment of Rakesh Patel as a Non-Executive Director04-15-15
IncellDx??????????????????????????????????????????????????????04-15-15
Aduro Biotech Announces Pricing of Its Initial Public Offering04-15-15
Celprogen Introduces a Novel Pharmacological Inhibitor CEP1430 for Human Pancreatic Cancer Patients04-15-15
THERAVECTYS sichert exklusiven Zugang zu Bibliothek für synthetische humanisierte Nanokörper am Institut Curie und stärkt seine proprietäre Immuntherapie-Plattform04-14-15
Cellectis Plant Sciences, Inc. Publishes a Study Demonstrating Reduced Acrylamide in Fried Potatoes04-14-15
Cellectis Plant Sciences publie une étude démontrant la réduction de la formation d?acrylamide dans les pommes de terre04-14-15
Riassunto: THERAVECTYS si assicura l'accesso esclusivo a una libreria di nano-anticorpi umanizzati sintetici dell'Istituto Curie e rafforza la sua piattaforma immunoterapica proprietaria04-14-15
Tolero Pharmaceuticals to Present Positive Advancement of Clinical and Preclinical Programs at the American Association for Cancer Research 201504-14-15
Akebia Therapeutics Announces Proposed Public Offering of Common Stock04-14-15
Biogen Presents New Anti-LINGO-1 Phase 2 Acute Optic Neuritis Data Demonstrating Neurological Repair04-14-15
Simulations Plus Reports Second Quarter FY2015 Financial Results04-14-15
Riassunto: Sartorius: informazioni supplementari sulle cifre dell'azienda per il 201404-14-15
Conventus Orthopaedics Receives FDA Clearance for PH Cage?, Proximal Humerus Implant Device04-14-15
California's Life Sciences Sector Applauds Gov. Brown on New Public-Private Precision Medicine Initiative04-14-15
Sartorius : Informations supplémentaires relatives aux chiffres 2014 de l?entreprise04-14-15
Samenvatting: IncellDx sluit overeenkomst met Claremont BioSolutions voor vermarkting nieuwe biopsietechnologie04-14-15
Phase III Trial of the Merck and NewLink Genetics Investigational Ebola Vaccine Initiated in Sierra Leone04-14-15
Mintz Levin Represents ImmunoGen, Inc. in $200 Million Transaction04-14-15
ProtoKinetix Announces Acquisition of Patents04-14-15
IMS Health Study: 2014 a Record-Setting Year for U.S. Medicines04-14-15
Treating the Whole Person: Interoperability and Coordinated Care in Action04-14-15
Innocrin Pharmaceuticals, Inc. Raises $28 Million in Series D Financing04-14-15
Envisia Therapeutics Names Dr. Rhett Schiffman Chief Medical Officer04-14-15
Lundbeck and ?Keep Memory Alive? Invest to Support Multiple System Atrophy Research and Global Taskforce04-14-15
Ortho Kinematics Raises $9.6 Million Series C Equity Financing04-14-15
Sartorius: Dynamisches erstes Quartal 2015 | Anhebung der Prognose04-14-15
Sartorius AG: Dynamic First Quarter | Forecast Revised Upwards04-14-15
Cranberries May Help in Lowering Diabetes Risk04-14-15
THERAVECTYS Secures Exclusive Access to a Synthetic Humanized Nanobody Library from Institut Curie and Strengthens Its Proprietary Immunotherapeutic Platform04-14-15
Convergent Dental Partners with Darby Dental Supply, LLC. to Increase Market Momentum of Leading Hard and Soft Tissue CO2 Dental Laser Solea04-14-15
Multiple Myeloma Research Foundation, University of Torino and Adaptive Biotechnologies Work to Speed Novel Minimal Residual Disease Monitoring Technologies to Patients04-14-15
Sunovion Pharmaceuticals Inc. to Present Data on Aptiom® (eslicarbazepine acetate) at 67th American Academy of Neurology Annual Meeting04-14-15
Puma Biotechnology Expands Cohort in Phase II Trial of PB272 in HER2 Mutation Positive Cancer Patients04-14-15
Waters UPLC I-Class/Xevo TQ-S System Approved for In Vitro Diagnostic Use in China04-14-15
DiscoveryBioMed, Inc. is developing a novel ?dual action? small molecule monotherapy for all cystic fibrosis (CF) patients04-14-15
Rosetta Genomics Completes Acquisition of PersonalizeDx04-14-15
Zoetis to Participate in the Bank of America Merrill Lynch 2015 Health Care Conference04-14-15
Ritter Pharmaceuticals Names Paul V. Maier to its Board of Directors04-14-15
Resumen: Sartorius: información suplementaria sobre cifras de negocio 201404-14-15
pSivida Corp. Reports ILUVIEN® for DME Approved in Poland04-14-15
Hydra Biosciences Receives Approval from Health Canada to Begin Phase 1 Trial for HX-10004-14-15
Teva and Eagle Pharmaceuticals Announce NDA for Bendamustine Rapid Infusion Product Accepted for Filing04-14-15
The 505(b)(2) Forum in Israel Will Review Case Studies and Strategies for 505(b)(2) Approval Pathway04-14-15
Beaufort to Sponsor AMDM Annual Meeting; New Hires to Speak at Thought Leadership Event04-14-15
Castle Biosciences Secures $6 Million Credit Facility from Silicon Valley Bank04-14-15
StemBioSys Closes $8 Million Series A Financing04-14-15
Incyte to Report First Quarter Financial Results on April 3004-14-15
Infinity Augments Executive Leadership Team, Appointing Chief Commercial Officer and General Counsel04-14-15
BioRestorative Therapies, Inc. Announces Opening of New Headquarters and Laboratory Facility in New York04-14-15
Courtagen Life Sciences Announced Today the Launch of New Tests for Epilepsy and Mitochondrial Disorders04-14-15
MetaStat CEO Oscar L. Bronsther, M.D. to Participate in Moffitt Cancer Center's 9th Annual Business of Biotech Conference in Tampa on April 1704-14-15
Incyte to Establish European Headquarters in Geneva, Switzerland04-14-15
Sartorius: Ergänzende Information zu den Geschäftszahlen 201404-14-15
Compugen Obtains Rights to Use Biological Systems and Materials from the US National Institutes of Health04-14-15
Sartorius: Supplementary Information on 2014 Business Figures04-14-15
NovaBay Pharmaceuticals Appoints Mark M. Sieczkarek Chairman04-14-15
Insulin Angel, The World's Smartest Medication Tracker, Launches on Indiegogo04-14-15
Research and Markets: Liquid Biopsy: An Emerging Market for Radically Improved Cancer Management04-14-15
IncellDx, Inc. Firma una Licencia Exclusiva con Claremont BioSolutions para Comercializar la Novedosa Tecnología de Biopsia de Base Líquida04-14-15
Sectra Launches Solution for Digital Primary Diagnostics in Pathology ? Enabling More Efficient Cancer Care04-14-15
IncellDx, Inc. signe un contrat de licence exclusif avec Claremont BioSolutions portant sur la commercialisation d'une technologie de biopsie liquide04-14-15
Resumen: Phlexglobal anuncia nombramiento de Rick Riegel como CEO04-14-15
Samenvatting: Phlexglobal benoemt Rick Riegel tot ceo04-14-15
IncellDx, Inc. Signs Exclusive License with Claremont BioSolutions to Commercialize Novel Liquid-Based Biopsy Technology04-14-15
Riassunto: IncellDx, Inc. stipula un contratto di licenza esclusiva con Claremont BioSolutions per la commercializzazione di una nuova tecnologia per biopsie basata su fluidi04-14-15
IncellDx Inc. unterzeichnet exklusive Lizenz mit Claremont BioSolutions zur Vermarktung neuer Biopsietechnologie auf Flüssigkeitsbasis04-14-15
IncellDx, Inc. assina licença exclusiva com a Claremont BioSolutions para comercializar nova tecnologia de biópsia baseada em líquido04-14-15
BioInvent: Cancer Cell Publishes Data Highlighting the Potential of Bioinvent's BI-1206 to Help Overcome Antibody Drug Resistance in Cancer Therapy04-14-15
The 23rd Colloque Médecine et Recherche in the Neurosciences series of the Fondation Ipsen: ?Micro-, meso- and macro-dynamics of the brain?04-14-15
Le 23ème Colloque Médecine et Recherche de la Fondation Ipsen de la série Neurosciences : «Micro-, méso- et macro- dynamiques cérébrales»04-14-15
Precise Biometrics Awarded the 2015 Frost & Sullivan Award for Global Customer Value Leadership in Fingerprint Biometrics for Mobile Devices04-14-15
Avedro Expands Patent Portfolio with Licenses from Caltech and IROC Innocross04-14-15
Tokai Pharmaceuticals Announces the Appointment of Cheryl Cohen, Former Medivation Chief Commercial Officer, to its Board of Directors04-13-15
Dyax Closes $230 Million Public Offering of Common Stock04-13-15
Cynvenio to Present New Clinical Data on Concordance Characteristics of Circulating Cell-Free Nucleic Acids in Metastatic Cancer Mutations at Molecular Diagnostics Europe04-13-15
Novacyt Raises ?2.2M to Accelerate NOVAprep Launch in China and Announces Strong First Quarter Sales Growth04-13-15
Samsung Showcases Connected Care Experience with Full Lineup of Products and Solutions at HIMSS 201504-13-15
Phlexglobal: Rick Riegel neuer Chief Executive Officer04-13-15
Phlexglobal annonce la nomination de Rick Riegel au poste de Président-directeur général04-13-15
Riassunto: Phlexglobal annuncia la nomina di Rick Riegel ad amministratore delegato04-13-15
Apervita Unveils the World's First Community and Marketplace for Health Analytics & Data04-13-15
Kolltan Pharmaceuticals Appoints Industry Veteran Frank Karbe to Its Board of Directors04-13-15
Ferring annuncia l'approvazione in Europa della nuova formulazione stabile a temperatura ambiente di DURATOCIN® (carbetocina)04-13-15
Panel of Experts Discuss Technology's Role in Fighting the Opiate Abuse Epidemic04-13-15
Ferring maakt Europese goedkeuring bekend van een nieuwe, op kamertemperatuur stabiele formulering van Pabal (carbetocine)04-13-15
Eagle Pharmaceuticals Appoints David M. Pernock to Its Board of Directors04-13-15
Hydra Biosciences and Boehringer Ingelheim Enter Research Collaboration Focused on Renal Diseases and Disorders04-13-15
Critical Path Institute Secures Regulatory Support for Skeletal Muscle Safety Biomarkers04-13-15
Cytori Provides Twelve Month Data Update on Scleradec-I Trial04-13-15
Teva to Present Multiple Sclerosis Data at 67th American Academy of Neurology (AAN) Annual Meeting in Washington, D.C.04-13-15
Hydra Biosciences and Boehringer Ingelheim Enter Research Collaboration Focused on Renal Diseases and Disorders04-13-15
Cologuard® Receives Coverage by Several Commercial Health Plans in Q1 201504-13-15
Seattle Genetics to Host Conference Call and Webcast Discussion of First Quarter 2015 Financial Results on April 30, 201504-13-15
RTI Surgical® Announces Agreement with Novation, One of the Nation's Leading Healthcare Services Companies04-13-15
Genzyme to Present New Long-Term Data on Aubagio® (teriflunomide) and Lemtrada® (alemtuzumab) at AAN04-13-15
UK's Aintree University Hospital Joins CEL-SCI's Phase III Head and Neck Cancer Trial04-13-15
Good Start Genetics Enters Exclusive License Agreement with Johns Hopkins University for Noninvasive Prenatal Testing (NIPT)04-13-15
ARCA biopharma Receives FDA Fast Track Designation for Gencaro? Atrial Fibrillation Development in a Genetically Targeted Heart Failure Population04-13-15
John Winkelman, M.D., Ph.D., Joins Flex Pharma's Scientific Advisory Board04-13-15
????????2015?????????????CRO????04-13-15
Nuance to Showcase New Clinical Documentation Tools for Mobile Devices and Wearables04-13-15
MPM Capital Appoints Gregory Sieczkiewicz as Managing Director and Chief Counsel ? Intellectual Property04-13-15
Ichor Medical Systems Announces Strategic Collaboration with Johnson & Johnson Innovation to Develop and Commercialize Immunotherapies Delivered with TriGrid Electroporation Device for Chronic Hepatitis B04-13-15
PatientsLikeMe and AstraZeneca Announce Global Research Collaboration04-13-15
Mach7 Technologies Partners with Broward Health04-13-15
Paolo Paoletti, M.D., Named To FORMA Therapeutics Board of Directors04-13-15
Research and Markets: PharmaLeaders: Mid-Cap Biotechnology Benchmark Report 2015 - Sales Forecasts and Product Valuations of Innovative Biotechs04-13-15
Arrowhead Cleared to Proceed with Multiple Dose Phase 2b Study of ARC-52004-13-15
New Book by Industry Thought Leaders Advocates for Re-Engineering Clinical Trials04-13-15
Despite Increased Use of Electronic Medical Records, Fewer U.S. Doctors Believe It Improves Health Outcomes, Accenture Survey Shows04-13-15
DitaExchange Grows Leadership Team with Software Industry Experts04-13-15
Next Generation Structured Content Management Solution Launched by DitaExchange04-13-15
Alkermes to Present Preclinical Data on Novel Selective Effector Cell Activator (SECA?) Immuno-Oncology Candidate at Upcoming American Association for Cancer Research Annual Meeting04-13-15
Blend Therapeutics Appoints Drew Fromkin as President and Chief Executive Officer04-13-15
Voyager Therapeutics Raises $60 Million in Oversubscribed Series B Financing04-13-15
Genelex Enables Genetic Risk Analysis and Precision Medicine in EHRs and Population Health Software with New APIs04-13-15
Trimel to Present at the 2015 Bloom Burton & Co. Healthcare Investor Conference04-13-15
Pacira Pharmaceuticals Announces Timing for First Quarter 2015 Financial Results Webcast and Conference Call04-13-15
Affymetrix and EverGene Ltd., a Subsidiary of MTI Ltd., Collaborate in Genetic Research and Personal Genomics Services in Japan04-13-15
Alexion Announces Presentations at 2015 American Transplant Congress, Including Results from Studies Advancing the Understanding of Eculizumab (Soliris®) in Patients Undergoing Kidney Transplant04-13-15
Research and Markets: Flow Cytometry - Global Strategic Business Report 2015-2020: Technological Advances Boost Cytometric System Sales04-13-15
Vitrolife AB (publ): Annual Report 201404-13-15
Torax Medical's LINX®, a Revolutionary Solution for GERD, to Be Highlighted at the Upcoming Society of American Gastrointestinal and Endoscopic Surgeons Annual Meeting04-13-15
Phlexglobal Announces Rick Riegel as Chief Executive Officer04-13-15
Accovion Signs Agreement to Be Acquired by Clinipace Worldwide04-13-15
Clinipace Worldwide Expands European Operations with Acquisition of Accovion04-13-15
Publication dans Retrovirology du mécanisme d'action d?ABX464, l'anti-VIH d'ABIVAX, premier d'une nouvelle classe thérapeutique04-13-15
IOmet Pharma Demonstrates Superior in Vivo PK/PD Properties in Pre-Clinical IDO1, TDO and Dual IDO1/TDO Cancer Immunotherapy Programs04-13-15
Eisai and Genomics plc to Collaborate in Analyses of Large-Scale Genotype/Phenotype Data to Inform Drug Development04-12-15
BIO Urges EPA to Get the Renewable Fuel Standard Back on Track04-10-15
2015 BIO International Convention to be held Jun 15 - 18, 2015, in Philadelphia, PA, US04-10-15
Riassunto: LFB nel 2014: crescita delle vendite internazionali e aumento dei profitti04-10-15
Hyalomatrix® Receives CMS Reimbursement Coverage in 11 States04-10-15
Samenvatting: LFB Group in 2014: Omzetgroei en grotere winstgevendheid04-10-15
Resumen: LFB Group en 2014: crecimiento de las ventas internacionales y rentabilidad al alza04-10-15
New Class of Orthopedic Implants for Intramedullary Biologic Fixation of Fractured Long Bones Validated in Preclinical Models04-10-15
Samenvatting: Quintiles op World Vaccine Congress 2015 uitgeroepen tot beste CRO04-10-15
???2015?????????????CRO ?04-10-15
???2015?????????????CRO ?04-10-15
Cerulean Closes Public Offering of Common Stock04-10-15
LFB Group 2014: Internationaler Umsatzanstieg und zunehmende Rentabilität04-10-15
PPD'sNBL???????????????????????????????04-10-15
Iowa Governor Terry Branstad to Speak at BIO World Congress on Industrial Biotechnology04-10-15
Replicor??2015???????????????????04-10-15
Replicor??2015??Lancet??????????????04-10-15
Replicor?2015????????????????????04-10-15
Dicerna Presents New ?-catenin Data from Multiple Tumor Models at the 2015 RNA & Oligonucleotide Therapeutics Meeting at Cold Spring Harbor Laboratory04-10-15
Embera NeuroTherapeutics Secures A-2 Financing to Advance EMB-001 for Addictions Through Phase 1 Clinical Trial04-10-15
LMK Clinical Research Consulting, LLC Gains Women's Business Enterprise Certification04-10-15
Le LFB en 2014 : une activité internationale en croissance et une rentabilité en hausse04-10-15
LFB Group in 2014: a Growth of International Sales and an Increasing Profitability04-10-15
Replicor to Present at the 2015 Lancet Viral Hepatitis Conference04-10-15
Research and Markets: Regulatory Trends in the US Pharma/Biotech Industry 201504-10-15
Karo Bio Acquires Product for Treatment of Common Cold04-10-15
Antibe Therapeutics Completes Final Closing of Non-Brokered Private Placement Bringing Total Proceeds to $1,250,00004-10-15
RECESS Study Reveals No Benefit to Transfusing Shorter-Storage Red Blood Cells for Cardiac Surgery Patients04-09-15
Cellectis Announces Presentations at Upcoming Conferences04-09-15
Cellectis interviendra à l?occasion de plusieurs conférences04-09-15
Quintiles Gana el Premio a la Mejor CRO en el Congreso Mundial de Vacunas de 201504-09-15
Quintiles remporte le prix du meilleur ORC au Congrès mondial de la vaccination de 201504-09-15
Exelixis to Release First Quarter 2015 Financial Results on Thursday, April 30, 201504-09-15
Vertex to Announce First Quarter 2015 Financial Results on April 2904-09-15
The Medicines Company Announces Preliminary Worldwide Net Revenue for the First Quarter of 201504-09-15
Research and Markets: Urinary Tract Infections Pipeline Highlights - 201504-09-15
Research and Markets: Global Pulmonary Hypertension Pipeline Highlights Report 2014-201504-09-15
Research and Markets: Chronic Myeloid Leukemia Pipeline Highlights - 201504-09-15
Research and Markets: Global Kidney Transplantation Pipeline Highlights Report 2014-201504-09-15
Alexion Pharmaceuticals to Report First Quarter 2015 Results on Thursday, April 23, 201504-09-15
MEDIAN Announces the Award of New Medical Image Interpretation and Management Projects for Clinical Trials for a Total of ?2.76M04-09-15
MEDIAN annonce de nouvelles attributions de projets d?interprétation et de gestion des images médicales dans les essais cliniques pour un montant cumulé de 2,76 M?04-09-15
Scripps Translational Science Institute Director Dr. Eric Topol to Deliver Keynote Address at the 2015 BIO International Convention04-09-15
Quintiles wird beim World Vaccine Congress 2015 als bestes Auftragsforschungsinstitut ausgezeichnet04-09-15
Quintiles recebe prêmio de Melhor Organização de Pesquisa Clínica (CRO) no Congresso Mundial de Vacinas de 201504-09-15
Riassunto: Quintiles vince il premio per la migliore CRO all?edizione 2015 del Congresso mondiale sui vaccini04-09-15
Vetter Announces Oliver Albrecht Has Been Appointed Managing Director04-09-15
IntriCon to Announce 2015 First-Quarter Results on Thursday, April 2304-09-15
PPD ? SNBL??????????????????????????04-09-15
PPD ? SNBL??????????????????????????04-09-15
Helomics? to Present at the Personalized Medicine World Conference in Oxford, England04-09-15
CRISPR Researchers Target Incurable Blood Cancer04-09-15
Biothera to Present Three Late-Breaking Posters at the American Association for Cancer Research Annual Meeting04-09-15
LFB BIOPHARMACEUTICALS Limited Takes over Promotion of LFB Group's Biopharmaceuticals in the United Kingdom04-09-15
MEDICREA : 2014 ANNUAL RESULTS AND Q1 2015 SALES04-09-15
Charles River Laboratories Schedules First-Quarter 2015 Earnings Release and Conference Call04-09-15
Bode Technology Supports Identification of Missing Persons in Cyprus Using DNA04-09-15
Research and Markets: Biomedical Photoacoustic Imaging Patent Landscape 201504-09-15
Aerpio Therapeutics to Present at the 14th Annual Needham Healthcare Conference04-09-15
REVOLUTION Medicines Appoints Pharmaceutical Commercial Executive Elizabeth McKee Anderson to Board of Directors04-09-15
Exelixis? Cabozantinib Granted Fast Track Designation by FDA For Advanced Renal Cell Carcinoma04-09-15
SCORR Marketing and Pharmaceutical Outsourcing Survey Reveals Trends in Contract Manufacturing04-09-15
ImmunoGen, Inc. Announces Conference Call to Discuss its Third Quarter Fiscal Year 2015 Financial Results04-09-15
Osiris Therapeutics Announces Alla Danilkovitch, Ph.D., as Chief Scientific Officer04-09-15
MEDI8897 Receives Fast Track Designation by the FDA for the Prevention of Respiratory Disease Caused by RSV in Infants04-09-15
Dyax Corp. to Participate in the 14th Annual Needham Healthcare Conference04-09-15
Quintiles wins Best CRO Award at World Vaccine Congress 201504-09-15
Resolutions of the Annual Shareholders? Meeting of Sartorius AG04-09-15
Beschlüsse der Hauptversammlung der Sartorius AG04-09-15
MetaStat Discussed in Medscape and Other News Outlets04-09-15
Edge Therapeutics Raises $72.5 Million Through Successive Series C-1 and C-2 Financings04-09-15
Opexa Therapeutics, Inc. Announces Completion of Rights Offering04-09-15
Kineta's Adjuvants Boost Flu Vaccine Effectiveness in Data Presented at World Vaccine Congress04-09-15
Janssen Highlights Hepatitis C Virus Development Programme at The International Liver Congress? 2015 of the European Association for the Study of the Liver (EASL)04-09-15
Gilead reicht Zulassungsantrag für neues Medikament mit Festdosiskombination von Emtricitabin/Tenofovir Alafenamid zur HIV-Behandlung bei U.S. Food and Drug Administration ein04-09-15
Cellectis Opens Labs and Offices in Manhattan, New York04-08-15
Colorado Governor Hickenlooper Signs Bill Ensuring Patient Access to Interchangeable Biologic Medicines04-08-15
Cardiovascular Systems to Webcast Fiscal 2015 Third-Quarter Earnings Conference Call Wednesday, April 2904-08-15
Alnylam to Webcast Presentation at 14th Annual Needham Healthcare Conference04-08-15
Research and Markets: Global Soft Tissue Sarcoma Pipeline Highlights Report 2014-201504-08-15
Research and Markets: Global Cervical Dysplasia Pipeline Highlights Report 2014-201704-08-15
Gilead presenta solicitud de nuevo fármaco ante la Administración de Alimentos y Fármacos de Estados Unidos para la combinación de dosis fija de emtricitabina/tenofovir alafenamida para el tratamiento del VIH04-08-15
Gilead soumet une Demande de drogue nouvelle auprès de la U.S. Food and Drug Administration pour une combinaison à dose fixe d'emtricitabine/ténofovir alafénamide pour le traitement du VIH04-08-15
Anika Therapeutics Files IDE Application with U.S. FDA for Hyalofast®04-08-15
Boston Strategic Corporation Announces Name To Strategia Therapeutics, Inc.04-08-15
Liquidia Technologies to Highlight PRINT® Technology at the World Vaccines Congress04-08-15
Gilead dient een aanvraag voor goedkeuring van een nieuw geneesmiddel in bij de Amerikaanse Food And Drug Administration voor Emtricitabine/Tenofovir Alafenamide voor de behandeling van HIV04-08-15
BioDirection, Inc. to Present at 5th Annual Traumatic Brain Injury Conference04-08-15
Purdue Startup Developing Self-Assembling, Bioinstructive Collagen Materials for Research, Medical Applications04-08-15
Cortendo AB Joins National Organization for Rare Disorders (NORD)® Corporate Council04-08-15
DiscoveryBioMed, Inc. is awarded a new Phase 2 SBIR grant award to develop new medicines to fight the diabetes and obesity epidemic in the US and globally04-08-15
Long Beach Memorial Now Offers Hip and Knee Procedures with New Advanced Robotic Arm Technology04-08-15
BioRestorative Therapies Appoints Charles S. Ryan, J.D., Ph.D. to its Board of Directors04-08-15
FORUM Pharmaceuticals Inc. to Participate in Needham & Company's 14th Annual Healthcare Conference04-08-15
SanBio Announces Pricing of Initial Public Offering on Tokyo Stock Exchange04-08-15
Allergen Research Corporation Expands Management with New VP Functions04-08-15
Padlock Therapeutics Initiates Collaborations with Three Leading Research Partners on the Biology of PAD Enzymes04-08-15
Research and Markets: Protein Engineering Market 2015 - Technology, Product, Protein Type, End User Analysis - Global Forecasts to 202004-08-15
Hydra Biosciences to Present at Needham & Company's 14th Annual Healthcare Conference04-08-15
PPD and SNBL Complete Joint Venture to Provide Japanese Clinical Development Services and Additional Collaborations04-08-15
Genocea to Present at the 14th Annual Needham & Co. Healthcare Conference04-08-15
Bristol-Myers Squibb Completes Previously Announced Acquisition of Flexus Biosciences, Inc.04-08-15
TKL Research to Present Interactive Webinar on Risk-Based Monitoring04-08-15
LabConnect Expanding to Advanced Laboratory Operations Center in Johnson City, Tennessee04-08-15
Theorem Clinical Research Thought Leaders to Present at Partnerships in Clinical Trials Conference04-08-15
MedData Launches Major Upgrades to Client Reporting Portal and iPhone App04-08-15
InVivo Therapeutics Announces Implementation of Reverse Stock Split in Preparation for Planned Uplisting to NASDAQ04-08-15
Aerie Pharmaceuticals to Present at the 14th Annual Needham Healthcare Conference04-08-15
SCIEX Launches P/ACE? MDQ Plus Capillary Electrophoresis System04-08-15
Cerulean to Present at 14th Annual Needham Healthcare Conference04-08-15
Trevena CEO to present at the 14th Annual Needham Healthcare Conference04-08-15
Grazoprevir/Elbasvir, Merck's Investigational Chronic Hepatitis C Therapy, Granted FDA Breakthrough Therapy Designations; New Phase 2 and 3 Data in Multiple HCV Patient Types to be Presented at The International Liver CongressTM 201504-08-15
Agenus Acquires Celexion Assets and Expands Its Antibody Discovery Platform04-08-15
Alzheon Announces $10 Million Series A Financing04-08-15
Alzheon Establishes New Corporate Headquarters04-08-15
HRS PatientConnect® Tablet Reduces Congestive Heart Failure Readmissions by 53% at Penn Medicine's Penn Care at Home04-08-15
Medivir: New simeprevir data will be presented at The International Liver Congress 2015 of the European Association for the Study of the Liver (EASL)04-08-15
Provectus Biopharmaceuticals to Present at 7th Annual International Partnering Conference, ChinaBio Partnering Forum 2015, Shanghai, China04-08-15
Enanta Pharmaceuticals Announces Data Presentations on Regimens Containing Protease Inhibitors Paritaprevir and ABT-493 at The International Liver Congress? 201504-08-15
Replicor to Make Six Presentations at EASL 201504-08-15
Notice to Attend the Annual General Meeting of Recipharm AB (Publ)04-08-15
Recipharm AB: Announcement from the nomination committee concerning the Annual General Meeting 201504-08-15
MEDA: Meda's annual report is published04-08-15
Ipsen and Hannover Medical School Start Joint Research in Recombinant Botulinum Neurotoxins for Targeted Secretion Inhibitors04-08-15
Ipsen et l'École de Médecine de Hanovre entament une recherche conjointe sur les neurotoxines botuliques recombinantes pour les inhibiteurs ciblés de la sécrétion04-08-15
Dr. Reddy's Laboratories and Its Subsidiary Promius PharmaTM Announce the Filing of Three NDAs With the USFDA04-08-15
Gilead deposita una domanda di approvazione di nuovo farmaco (New Drug Application, NDA) presso l?ente statunitense preposto al controllo dei farmaci e degli alimenti (Food and Drug Administration, FDA) per il regime combinato a dosaggio...04-08-15
Dyax Announces Pricing of $200 Million Public Offering of Common Stock04-08-15
Gilead Submits New Drug Application to U.S. Food and Drug Administration for Fixed-Dose Combination of Emtricitabine/Tenofovir Alafenamide for HIV Treatment04-07-15
Provision First Proton Therapy Center Using New Product to Benefit Prostate Cancer Patients04-07-15
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, April 22, 201504-07-15
Baxter International First Quarter 2015 Financial Results Conference Call04-07-15
RetroSense Therapeutics Selected as Finalist for Prestigious Angel Investor Award04-07-15
Big Data, Social Media and Patient Engagement Keynotes Reflect Dramatic Changes in Clinical Research at PCT 201504-07-15
CUMBRE ECONÓMICA EN PUERTO RICO COMO PUERTA DE ENTRADA A LOS ESTADOS UNIDOS04-07-15
Ferring announces European approval of new room temperature stable formulation of PABAL® (carbetocin)04-07-15
Technavio Publishes Global Biobanking Market Analysis and Forecast 2015-201904-07-15
N-of-One to Provide Clinical Interpretation to the Diagnostic Laboratories Awarded the US Department of Veteran Affairs Contract for Clinical Cancer Genomic Testing in New England04-07-15
Our Vision is to Cure Alzheimer's Disease: Health Connexions and Recombinant Technologies Announce a Ground-Breaking Partnership to Accelerate Success in Alzheimer's Disease04-07-15
Samenvatting: MedDay geeft update over fase 3-onderzoek naar medicijn tegen progressieve MS04-07-15
Résolutions de l'Assemblée générale mixte des actionnaires de Sartorius Stedim Biotech04-07-15
Promega Nano-Glo® Dual-Luciferase® Reporter Assay Enables More Sensitive Detection of Cellular Events with Greater Flexibility in Assay Design04-07-15
Raze Therapeutics Appoints Mark Manfredi as Chief Scientific Officer04-07-15
ACADIA Pharmaceuticals to Present at the 14th Annual Needham Healthcare Conference on April 14, 201504-07-15
Simulations Plus Sets Date for 2nd Quarter 2015 Earnings Release and Conference Call04-07-15
ArQule, Inc. to Present at 14th Annual Needham Healthcare Conference04-07-15
Vaxart to Present at the 14th Annual Needham Healthcare Conference in New York City on Tuesday, April 14, 201504-07-15
One Lambda, Inc. Announces the Availability of the Only FDA Cleared IVD Test for Detecting HNA-304-07-15
Agendia Announces Recommendation of MammaPrint in Germany's AGO Guidelines, at St. Gallen International Breast Cancer Conference04-07-15
Euclises Completes Financing Round04-07-15
Research and Markets: 3D Bioprinting: Transforming The Future of Healthcare Sector - Technical Insights Report 201504-07-15
Madison Vaccines to Present at the 2015 World Vaccine Congress in Washington, D.C., on April 9th04-07-15
Interleukin Genetics Appoints Mark B. Carbeau as CEO04-07-15
Global Strategic Partners Merck KGaA, Darmstadt, Germany, and Pfizer Finalize Agreement to Co-Promote XALKORI® (crizotinib)04-07-15
Montana Primary Care Association Selects eClinicalWorks for HEDIS Performance04-07-15
Admera Health Completes Series A Financing04-07-15
CRISPR Therapeutics to Establish R&D Operations in Cambridge, Massachusetts04-07-15
AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2015 Earnings Release04-07-15
WaVe Life Sciences Appoints Roberto Guerciolini, M.D., as Senior Vice President and Head of Early Development04-07-15
Biogen Data at AAN Annual Meeting Underscore Commitment to Advancing Patient Care in Neurology04-07-15
Concert Pharmaceuticals to Present at 14th Annual Needham Healthcare Conference04-07-15
Acceleron Announces Oral Presentations of Luspatercept and Sotatercept Data at the 13th International Symposium on Myelodysplastic Syndromes04-07-15
GlycoMimetics Provides Update on Pfizer's Plans to Initiate Phase 3 Trial with Rivipansel in Mid-201504-07-15
True North Therapeutics Announces $35 Million Series B Financing04-07-15
Illumina to Announce First Quarter 2015 Financial Results on Tuesday, April 21, 201504-07-15
Cerulean Announces Pricing of Public Offering of Common Stock04-07-15
Provectus Biopharmaceuticals? Data on PV-10 to Be Presented at HemOnc Today Melanoma and Cutaneous Malignancies Annual Meeting04-07-15
MedDay veröffentlicht weitere Informationen zum Design einer bahnbrechenden, zulassungsrelevanten Phase-III-Studie zu progredienter multipler Sklerose04-07-15
MedDay fait le point sur la conception novatrice d'une étude pivot de phase III sur la sclérose en plaques progressive04-07-15
Resumen: MedDay ofrece nuevos datos del diseño del estudio fundamental de Fase III sobre la esclerosis múltiple04-07-15
MedDay provides update on pioneering pivotal Phase III study design in Progressive Multiple Sclerosis04-07-15
Riassunto: MedDay annuncia un aggiornamento relativo all'innovativa progettazione degli studi clinici pivotal di fase III sulla sclerosi multipla progressiva04-07-15
Ocular Therapeutix? Reports Topline Clinical Data for its Second Phase 3 Clinical Trial Evaluating OTX-DP for the Treatment of Post-Surgical Ocular Inflammation and Pain04-06-15
PerkinElmer to Hold Earnings Call on Thursday, April 30, 201504-06-15
Clovis Oncology Receives Breakthrough Therapy Designation for Rucaparib for Monotherapy Treatment of Advanced Ovarian Cancer in Patients with BRCA-mutated Tumors (Inclusive of both Germline and Somatic BRCA Mutations)04-06-15
Dyax Announces Proposed Public Offering of 7,000,000 Shares of Common Stock04-06-15
Affymetrix to Report First Quarter 2015 Operating Results on Wednesday April 29, 201504-06-15
Kedrion Biopharma Inc. Announces Advanced Manufacturing Methods Used to Further Enhance Safety Profile of Koate® Double Viral Inactivation (DVI) Antihemophilic Factor (human)04-06-15
Celprogen Introduces STEMC5007, a Stem Cell Activator / Stimulator That Increases Stem Cell Proliferation and Their Regenerative Potentials for Major Organ Systems04-06-15
First US Patient Implanted with BIOTRONIK Eluna Pacemaker System with Full-Body ProMRI Technology04-06-15
Impact Education, LLC launches The Managed Care Review Board?, an innovative online resource and continuing education curricula for managed care professionals04-06-15
Breakout Labs and Becton, Dickinson and Company Partner to Provide Capital and Expertise to Biomedical Startups04-06-15
Kathrin U. Jansen, Ph.D., to Lead Pfizer's Vaccine Research and Development Unit04-06-15
Synta Pharmaceuticals Closes Public Offering of Common Stock04-06-15
Insmed Announces Closing of Public Offering and Exercise of Option to Purchase Additional Shares04-06-15
UK National Graphene Institute Selects Bruker as Official Partner04-06-15